2 2 1 2 will be smaller. Thus, estimates of the mixed fourth moments can be used to test for partial genetic causality and to estimate the GCP. We note that LCV, unlike MR, does not distinguish between the 'exposure' and the 'outcome'; trait 1 and trait 2 are interchangeable labels. 
M
endelian randomization (MR) is widely used to identify potential causal relationships among heritable traits, potentially leading to new disease interventions [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . Genetic variants that are significantly associated with one trait, the 'exposure' , are used as genetic instruments to test for a causal effect on a second trait, the 'outcome' . If the exposure is causal, then variants affecting the exposure should affect the outcome proportionally. For example, low-density lipoprotein (LDL) 3, 13 and triglycerides 4 (but not high-density lipoprotein (HDL) 3 ) causally affect coronary artery disease risk. However, pleiotropy presents a challenge for MR, especially when it produces a genetic correlation and when the exposure is highly polygenic 2, 11, 12, [14] [15] [16] . Sometimes, this challenge can be addressed using curated genetic variants without pleiotropic effects; this approach is most appropriate for molecular traits (such as LDL). For other complex traits, statistical approaches have been used to reduce the likelihood of confounding, such as MR-Egger 7 and bidirectional MR 11, 17, 18 . However, these approaches have their own limitations.
We introduce a latent causal variable (LCV) model, under which the genetic correlation between two traits is mediated by a latent variable having a causal effect on each trait. We define trait 1 as partially genetically causal for trait 2 when it is strongly correlated with the causal variable, implying that part of the genetic component of trait 1 is causal for trait 2. We quantify partial causality using the genetic causality proportion. We show in simulations that LCV has major advantages over MR methods, and we apply it to 52 diseases and complex traits.
Results
Overview of methods. The LCV model is based on a latent variable L that mediates the genetic correlation between the two traits (Fig. 1a) . Under the LCV model, trait 1 is fully genetically causal for trait 2 if it is perfectly genetically correlated with L; 'fully' means that the entire genetic component of trait 1 is causal for trait 2 (Fig. 1b) . More generally, trait 1 is partially genetically causal for trait 2 if the latent variable has a stronger genetic correlation with trait 1 than with trait 2; 'partially' means that part of the genetic component of trait 1 is causal for trait 2. To quantify partial causality, we define the genetic causality proportion (GCP) of trait 1 on trait 2. The GCP ranges between 0 (no partial genetic causality) and 1 (full genetic causality). A high value of GCP (even if it is not exactly 1) implies that interventions targeting trait 1 are likely to affect trait 2. An intermediate value implies that some interventions targeting trait 1 may affect trait 2. (However, we caution that an intervention may fail to mimic genetic perturbations, for example due to its timing relative to disease progression.) For example, a recent study suggested either a fully causal effect of age at menarche (AAM) on height or a shared hormonal pathway affecting both traits 11 . If this shared pathway (modeled by the LCV, L) has a large effect on AAM but a small effect on height, then AAM would be strictly partially genetically causal for height. Indeed, LCV produced an intermediate GCP estimate ( = .
. . = . GCP 0 43 (s e 0 10); see below). We caution that low GCP estimates are not evidence of full genetic causality, and we refer to trait pairs with low GCP estimates as having limited partial genetic causality. LCV P values test the null hypothesis that GCP = 0, and a highly significant P value does not imply a high GCP.
To test for partial genetic causality and to estimate the GCP, we exploit the fact that, if trait 1 is partially genetically causal for trait 2, then most SNPs affecting trait 1 will have proportional effects on trait 2, but not vice versa (Fig. 1c-e) . Instead of using thresholds to select subsets of SNPs 11 , we compare the mixed fourth moments α α α E ( )
1 2 of marginal effect sizes (α 1 and α 2 , respectively) for each trait. The rationale for utilizing these mixed fourth moments is that, if trait 1 is causal for trait 2, then SNPs with large effects on trait 1 (large α 1 2 ) will have proportional effects on trait 2 (large α 1 α 2 ), so that α α α E ( ) 1 2 1 2 will be large; conversely, SNPs with large effects on trait 2 (large α 2 2 ) will generally not affect trait 1 (small α 1 α 2 ), so that α α α E ( ) LCV assumes that joint effect-size distribution for two traits is a sum of two independent distributions: (1) a shared genetic component corresponding to L, whose values are proportional for both traits, and (2) a distribution that does not contribute to the genetic correlation (see Online Methods). We interpret the first distribution as 'mediated' effects (corresponding to π; Fig. 1a ) and the second distribution as 'direct' effects (corresponding to γ). The LCV model assumption is strictly weaker than the 'exclusion restriction' assumption of MR (see Online Methods).
Under the LCV model, the genetic causality proportion is defined as the number x such that:
where q k is the normalized effect of L on trait k (Fig. 1a) , and ρ g is the genetic correlation 16 (note that ρ g = q 1 q 2 ). When the GCP is equal to 1, trait 1 is fully genetically causal for trait 2; when it is positive but less than 1, trait 1 is partially genetically causal. When it is negative, trait 2 is partially genetically causal. The GCP can be defined without making LCV (or other) model assumptions (see Online Methods).
To estimate the GCP, we utilize the following relationship between the mixed fourth moments of the marginal effect-size distribution and the parameters q 1 and q 2 :
. We estimate the variance of these statistics using a block jackknife and obtain an approximate likelihood function for the GCP. We compute a posterior mean GCP estimate (and a posterior standard deviation) using a uniform prior. We test the null hypothesis (that GCP = 0) using S(0). Details of the method are provided in the Online Methods. We have released open source software implementing the LCV method (see URLs).
Simulations. To compare the calibration and power of LCV with existing causal inference methods, we performed a wide range of null and causal simulations involving simulated summary statistics with no LD. We compared four main methods: LCV, random-effect two-sample MR 5, 9 (denoted MR), MR-Egger 7 , and bidirectional MR 11 (see Online Methods). We also compared LCV with the weighted median estimator (MR-WME) 8 and mode-based estimator (MR-MBE) 10 (whose performances were roughly similar to MR and MR-Egger, respectively; results using these methods are reported in the supplementary tables). We applied each method to simulated genome-wide association study (GWAS) summary statistics (n = 100,000 individuals in each of two non-overlapping cohorts; M = 50,000 independent SNPs 20 ) for two heritable traits (h 2 = 0.3), generated under the LCV model. LCV uses LD score regression 19 ; for simulations with no LD, we use constrainedintercept LD score regression (simulations with LD are described below). A detailed description of all simulations is provided in the Supplementary Note, and simulation parameters are described in Supplementary Table 1 .
First, we performed null simulations (GCP = 0) with uncorrelated pleiotropic effects (via γ; Fig. 1a ) and zero genetic correlation. Of the SNPs, 1% were causal for both traits (with independent effect sizes, explaining 20% of heritability for each trait), and 4% were causal for each trait exclusively ( Fig. 2a and Supplementary Table 2a-d). LCV produced conservative P values (0.0% false positive rate at α = 0.05); our normalization of the test statistic can lead to conservative P values when the genetic correlation is low (see Online Methods). All three main MR methods produced well-calibrated P values. Even though the 'exclusion restriction' assumption of MR is violated here, these results confirm that uncorrelated pleiotropic effects do not confound random-effect MR at large sample size 21 .
(Such pleiotropy is known to cause false positives if a less conservative fixed-effect approach is used 22 .) In these simulations, all methods except LCV used the set of approximately 170 SNPs (on average) that were genome-wide significant (P < 5 × 10 −8 ) for trait 1 (or approximately 330 SNPs that were genome-wide significant for either trait, in the case of bidirectional MR).
Second, we performed null simulations with a non-zero genetic correlation. Of the SNPs, 1% had causal effects on L, and L had effects = = .
0 2 1 2 on each trait (so that ρ g = 0.2); 4% were causal for each trait exclusively ( Fig. 2b and Supplementary Table 2e-g). MR and MR-Egger both produced excess false positives, while bidirectional MR and LCV produced well-calibrated P values. These simulations violate the MR-Egger assumption that the magnitude of pleiotropic effects on trait 2 are independent of the magnitude of effects on trait 1 (the 'InSIDE' assumption) 7 , as SNPs with larger effects on L have larger effects on both trait 1 and trait 2 on average, consistent with known limitations 22 . Third, we performed null simulations with a non-zero genetic correlation and differential polygenicity in the non-shared genetic architecture between the two traits. Of the SNPs, 1% were causal for L, with effects = = .
0 2 1 2 on each trait; 2% were causal for trait 1 but not trait 2; and 8% were causal for trait 2 but not trait 1 ( Fig. 2c and Supplementary Table 2h-j) . Thus, the likelihood that a SNP would be genome-wide significant was higher for causal SNPs affecting trait 1 only than for causal SNPs affecting trait 2 only. As a result of this imbalance, bidirectional MR (as well as other MR methods) produced excess false positives, unlike LCV.
Fourth, we performed null simulations with a non-zero genetic correlation and differential power for the two traits, reducing the sample size from 100,000 to 20,000 for trait 2. Of the SNPs, 0.5% were causal for L, with effects = = .
0 5 1 2 on each trait, and 8% were causal for each trait exclusively ( Fig. 2d and Supplementary Table 2k-m). Because per-SNP heritability was higher for shared causal SNPs than for non-shared causal SNPs, shared causal SNPs were more likely to reach genome-wide significance in the smaller trait 1 sample (n = 20,000), leading to a similar imbalance as in Fig. 2c . As a result, bidirectional MR (as well as other MR methods) produced excess false positives, while LCV produced wellcalibrated P values.
Next, we performed causal simulations (with full genetic causality) to assess whether LCV is well powered to detect a causal effect. We caution that LCV had lower power in simulations with LD (see below). First, we chose a set of default parameters: n = 25,000 for each trait, 5% of SNPs causal for trait 1 (the causal trait), a (fully) causal effect of size q 2 = 0.2 of trait 1 on trait 2, and 5% of SNPs causal for trait 2 only (Fig. 3a ). There were ~15 genome-wide significant SNPs on average, explaining ~2% of h 2 . LCV was well powered to detect a causal effect at α = 0.001, while MR had lower power and bidirectional MR and MR-Egger had very low power.
Second, we reduced the sample size for trait 1 ( Fig. 3b and Supplementary Table 3b-d), finding that LCV had high power while the MR methods had very low power, owing to the small number of genome-wide significant SNPs. We caution that, for real traits, heritability estimates can be noisy at very low sample size, potentially leading to unreliable results (see Supplementary Note and "Application to real traits", below).
Third, we reduced the sample size for trait 2 ( Fig. 3c and Supplementary Table 3e-g). LCV had high power, while other methods had low power. The effect of trait 2 sample size on MR power was more modest than the effect of trait 1 sample size, suggesting that the number of genome-wide significant SNPs (ascertained using trait 1) is the primary limiting factor for MR power.
Fourth, we reduced the causal effect size of trait 1 on trait 2 ( Fig. 3d and Supplementary Table 3h-j). LCV had low power, and other methods had very low power. Fifth, we increased the polygenicity of the causal trait ( Fig. 3e and Supplementary Table 3k-m). LCV had moderate power, while the MR methods had very low power, again owing to the low number of genome-wide significant SNPs. We also simulated a partially genetically causal relationship (GCP = 0.25-0.75), with similar results (Supplementary  Table 3p -r). We compared our GCP estimates in fully causal simulations with our GCP estimates in partially causal simulations, finding that LCV reliably distinguished the two cases, unlike existing methods (Supplementary Table 3a ,p-r).
To investigate potential limitations of our approach, we performed null and causal simulations under genetic architectures that violate LCV model assumptions. These simulations and their results are described in detail in the Supplementary Note. We simulated four types of LCV model violations: (1) null simulations with a bivariate Gaussian mixture model, where one of the mixture components generates imperfectly correlated effect sizes on the two traits; (2) null simulations with two LCVs; (3) causal simulations with a bivariate Gaussian mixture model; and (4) causal simulations with an additional latent confounder. LCV produced well-calibrated P values under models of type 1 ( Supplementary  Fig. 1a-c) ; in addition, these simulations recapitulated the limitations of existing methods (Fig. 2) . Models of type 2 sometimes caused LCV (and existing methods) to produce false positives ( Supplementary  Fig. 1d,e) ; however, extreme values of the simulation parameters were required for LCV to produce high GCP estimates, implying that results with high GCP estimates are extremely unlikely to be false positives (Supplementary Fig. 2 ). Causal models of type 3 and type 4 lead to reduced power for LCV (and other methods; Supplementary Fig. 1f,g ), as well as downwardly biased GCP estimates for LCV (Supplementary Tables 4 and 5) .
Next, we performed simulations with real LD patterns to further assess the robustness of the LCV method. These simulations and their results are described in detail in the Supplementary Note. In null simulations with a wide range of parameter settings, LCV produced approximately well-calibrated or conservative false positive rates, except for simulations at low sample size with noisy heritability estimates (Supplementary Tables 6a-s and 7) . (We exclude real datasets with noisy heritability estimates.) We determined that LCV can be confounded by uncorrected population stratification (Supplementary Table 8 ). In non-null simulations, LCV was usually well powered to detect a causal or partially causal effect (Supplementary Table 6t -bb). In simulations with a range of GCP values, we determined that our posterior mean GCP estimates are approximately unbiased and that our posterior standard errors are approximately well calibrated ( Supplementary Fig. 3 and Supplementary Table 9 ).
Application to real traits. We applied LCV and the MR methods to GWAS summary statistics for 52 diseases and complex traits, including summary statistics for 37 UK Biobank traits 23, 24 computed using BOLT-LMM 25 (average n = 429,000) and 15 other traits (average n = 54,000) (see Supplementary Table 10 and Online Methods). These traits were selected on the basis of the significance of their heritability estimates (Z h > 7), and trait pairs with very high genetic correlations (|ρ g | > 0.9) were pruned. As in previous work, we excluded the major histocompatibility complex region from all analyses, due to its unusually large effect sizes and long-range LD patterns 19 . We applied LCV to the 429 trait pairs (32% of all trait pairs) with a nominally significant genetic correlation (P < 0.05), detecting significant evidence of full or partial genetic causality for 59 trait pairs (FDR < 1%), including 30 trait pairs with GCP > 0.6. We primarily focus on trait pairs with high GCP estimates, which have greater biological interest (and are extremely unlikely to be false positives; see "Simulations"). Results for selected trait pairs are displayed in Fig. 4 , results for the 30 trait pairs with GCP > 0.6 are reported in Table 1 , results for all 59 significant trait pairs are reported in Supplementary  Table 11 , and results for all 429 genetically correlated trait pairs are reported in Supplementary Table 12 . To investigate the possibility that these results could be affected by model misspecification, we developed an auxiliary test for partial genetic causality that does not rely on LCV model assumptions (Supplementary Note). This test, though underpowered, produces highly concordant results on these trait pairs, confirming that LCV is unlikely to be affected by model misspecification.
Myocardial infarction (MI) had a nominally significant genetic correlation with 31 other traits, of which six had significant evidence (FDR < 1%) for a fully or partially genetically causal effect on MI (Table 1) ; there was no evidence for a genetically causal effect of MI on any other trait. Consistent with previous studies, these traits included LDL 3, 13 , triglycerides 4 , and body mass index (BMI) 26 , but not HDL 3 . The effect of BMI was also consistent with previous MR studies [26] [27] [28] [29] , although these studies did not attempt to account for pleiotropic effects (also see ref. 30 , which detected no effect). There was also evidence for a genetically causal effect of high cholesterol, which was unsurprising (due to the high genetic correlation with LDL) but noteworthy because of its strong genetic correlation with MI, compared with LDL and triglycerides. The result for HDL and MI did not pass our significance threshold (FDR < 1%) but was nominally significant (P = 0.02; Supplementary Table 12) ; we residualized HDL summary statistics on summary statistics for three established causal risk factors (LDL, BMI, and triglycerides), determining that residualized HDL showed no evidence of genetic causality (P = 0.8). However, most of the other traits remained significant (Supplementary Table 13 ).
We also detected evidence for a fully or partially genetically causal effect of hypothyroidism on MI (Table 1) . Although hypothyroidism is not as well established a cardiovascular risk factor as high LDL, its genetic correlation with MI is comparable (Table 1) , and this effect is mechanistically plausible 31, 32 . While this result was robust in the conditional analysis (Supplementary Table 13) , and there was no strong evidence for a genetically causal effect of hypothyroidism on lipid traits (Supplementary Table 12 ), it is possible that this effect is mediated by lipid traits. A recent MR study of thyroid hormone levels, at ~20× lower sample size than the present study, provided evidence for a genetically causal effect on LDL but not coronary artery disease 33 . However, clinical trials have demonstrated that treatment of subclinical hypothyroidism leads to improvement in several cardiovascular risk factors [34] [35] [36] [37] [38] . We also detected evidence for a fully or partially genetically causal effect of hypothyroidism on type 2 diabetes (Supplementary Table 11 ), consistent with a longitudinal association between subclinical hypothyroidism and diabetes incidence 39 , as well as an effect of thyroid hormone withdrawal on glucose disposal in athyreotic patients 40 .
We detected evidence for a (negative) genetically causal effect of LDL on bone mineral density (BMD; Table 1 ). A meta-analysis of randomized clinical trials reported that statin administration increases BMD 41 . Moreover, familial defective apolipoprotein B leads to high LDL and low BMD 42 . We performed two-sample MR using eight SNPs that were previously curated (in ref. 3 ; see Supplementary Note), finding modest evidence for a negative causal effect (P = 0.04). Because these variants are not likely to have pleiotropic effects, this analysis provides separate evidence for a genetically causal effect. Additional trait pairs with high GCP estimates are discussed in the Supplementary Note.
Approximately half of significant trait pairs had low to medium GCP estimates (< 0.6). Given that there is lower power to detect trait pairs with low GCP values (Supplementary Table 3a ,p-r), it is likely that partial genetic causality with GCP < 0.6 is more common than full or nearly full genetic causality with GCP > 0.6. Trait pairs with low GCP estimates can suggest plausible biological hypotheses. For example, we identified a partially genetically causal effect of AAM on height ( GCP = 0.43(0.10); Supplementary Table 11 ), suggesting that these traits are influenced by a shared hormonal pathway that is more strongly correlated with AAM than with height, as recently hypothesized 11 . A recent study reported genetic correlations between various complex traits and number of children in males and females 43 . We identified only one trait (balding in males) with a fully or partially causal effect on number of children (in males; Table 1 Table 12) . Thus, a genetic correlation with number of children does not imply direct selection. This result does not contradict the conclusion 43 that complex traits are affected by natural selection, as pleiotropic selection can also affect a trait 44 . Polygenic autism risk is positively genetically correlated with educational attainment 16 (and cognitive ability 45 , a highly genetically correlated trait 46 ), possibly consistent with the hypothesis that common autism risk variants persist in the population due to compensatory effects on cognitive ability 47, 48 . If so, then most common variants affecting autism risk would also affect educational attainment, leading to a partially genetically causal effect of autism on educational attainment. However, we detected evidence against such an effect ( ρ = .
.̂= . . GCP 0 13(0 13), 023(0 07) g ; Supplementary Table 12 ). Additional trait pairs with negative results are reported in the Supplementary Note and in Supplementary Table 14 .
To evaluate whether the limitations of MR observed in simulations (Fig. 2) are also observed in analyses of real traits, we applied MR, MR-Egger, and bidirectional MR to all 429 genetically correlated trait pairs (Supplementary Table 12 ). MR reported significant causal relationships (1% FDR) for 271 of 429 trait pairs, including 155 pairs of traits for which each trait was reported to be causal for the other trait. This implausible result confirms that MR frequently produces false positives in the presence of a genetic correlation, as predicted by our simulations (Fig. 2) . In contrast, LCV reported a significant partially or fully genetically causal relationship for only 59 trait pairs (Supplementary Table 11) , and it never reports a causal effect in both directions. Similarly, bidirectional MR reported a significant causal relationship for only 45 trait pairs (including 17 pairs of traits that overlapped with LCV; Supplementary Table 15 ).
Discussion
We have introduced an LCV model to identify causal relationships among genetically correlated pairs of complex traits. We applied LCV to 52 traits, finding that many trait pairs do exhibit partially or fully genetically causal relationships. Our method represents an advance for two main reasons. First, unlike existing MR methods, LCV reliably distinguishes between genetic correlation and full or partial genetic causation. Positive findings using LCV are more likely to reflect true causal effects. Second, we define and estimate the GCP to quantify the degree of causality. This parameter, which provides information orthogonal to the genetic correlation or the causal effect size, enables a non-dichotomous description of the causal architecture.
This study has two important limitations (additional limitations are discussed in the Supplementary Note). First, the LCV model includes only a single intermediary and can be confounded in the presence of multiple intermediaries 49 . However, the 30 trait pairs with ̂> . GCP 0 6 are unlikely to be false positives (see Supplementary Note and Supplementary Fig. 2 ). Second, because LCV models only two traits at a time, it cannot be used to identify conditional effects given observed confounders 4, 50 . This approach was used, for example, to show that triglycerides affect coronary artery disease risk conditional on LDL 4 . However, it is less essential for LCV to model observed genetic confounders, since LCV explicitly models a latent genetic confounder Color scale indicates posterior mean GCP for the effect of the row trait on the column trait; blue color indicates > GCP 0.6, gray color indicates GCP < 0.6. Plus or minus signs indicate trait pairs with a nominally significant positive or negative genetic correlation (P < 0.05); the size of the symbol is proportional to strength of the genetic correlation. Results for the 30 trait pairs with GCP > 0.6 are reported in Table 1 , results for all 59 significant trait pairs are reported in Supplementary Table 11 , and results for all 429 genetically correlated trait pairs are reported in Supplementary  Table 12 . TG, triglycerides; HC, high cholesterol; HTHY, hypothyroidism; T2D, type II diabetes; FEV1FVC, ratio of forced expiratory volume to forced vital capacity; PDW, platelet distribution width; BPD, bipolar disorder; SCZ, schizophrenia; BrCa, breast cancer; PrCa, prostate cancer.
Despite these limitations, for most pairs of complex traits, we recommend using LCV instead of MR, as MR methods (including MR-Egger) are easily confounded by genetic correlations. MR is more reliable when it is possible to identify variants that are likely to represent valid instruments. For example, an MR analysis identified a causal effect of vitamin D on multiple sclerosis, utilizing genetic variants near genes with well-characterized effects on vitamin D synthesis, metabolism, and transport 52 . As another example, cis-eQTLs can be used as genetic instruments, as they are unlikely to be confounded by processes mediated in trans [53] [54] [55] ; however, this approach has other limitations 54, 56 .
URLs. Open-source software implementing our method is available at https://github.com/lukejoconnor/LCV.
Online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/ s41588-018-0255-0. We report all significant trait pairs (1% FDR) with high GCP estimates ( GCP > 0.6). P LCV is the P value for the null hypothesis of no partial genetic causality; ρ g is the estimated genetic correlation, with standard error; GCP is the posterior mean estimated genetic causality proportion, with posterior standard error. We provide references for all MR studies supporting causal relationships between these traits that we are currently aware of. Results for all 59 significant trait pairs are reported in Supplementary Table 11 , and results for all 429 genetically correlated trait pairs are reported in Supplementary Table 12 .
Methods LCV model. The LCV random effects model assumes that the distribution of marginal effect sizes for the two traits can be written as the sum of two independent bivariate distributions (visualized in Fig. 1c -e in orange and blue, respectively): (1) a shared genetic component (q 1 π, q 2 π) whose values are proportional for both traits, and (2) an even genetic component (γ 1 ,γ 2 ) whose density is mirror symmetric across both axes. Distribution 1 resembles a line through the origin, and we interpret its effects as being mediated by an LCV (L) (Fig. 1a) ; distribution 2 does not contribute to the genetic correlation, and we interpret its effects as direct effects. Informally, the LCV model assumes that any asymmetry in the shared genetic architecture arises from the action of a latent variable.
In detail, the LCV model assumes that there exist scalars q 1 , q 2 and a distribution (π,γ 1 ,γ 2 ) such that: where π ⊥ (γ 1 ,γ 2 ) and (γ 1 , γ 2 ) ~ (− γ 1 , γ 2 ) ~ (γ 1 , − γ 2 ). Here α k is the random marginal effect of a SNP of trait k, π is interpreted as the marginal effect of a SNP on L, and γ k is interpreted as the non-mediated effect of a SNP on trait k. α and π (but not γ) are normalized to have unit variance, and all random variables have zero mean. (The symbol ~ means 'has the same distribution as. ') q 1 , q 2 are the model parameters of primary interest, and we can relate them to the mixed fourth moments, which are observable (equation (2)). In particular, this implies that the model is identifiable (except when the excess kurtosis κ π = 0; see Supplementary Note). We do not expect that κ π will be exactly zero for any real trait, but there will be lower power for traits with higher polygenicity. Note that we have avoided assuming any particular parametric distribution. The LCV model assumptions are strictly weaker than the assumptions made by MR. Like LCV, a formulation of the MR assumptions is that the bivariate distribution of SNP effect sizes can be expressed in terms of two distributions. In particular, it assumes that the effect-size distribution is a mixture of (1ʹ ) a distribution whose values are proportional for both traits (representing all SNPs that affect the exposure Y 1 ) and (2ʹ ) a distribution with zero values for the exposure Y 1 (representing SNPs that only affect the outcome Y 2 ). These two distributions can be compared with distributions 1 and 2 above. Because 1ʹ is identical to 1 and 2ʹ is a special case of 2ʹ , the LCV model assumptions are strictly weaker than the MR assumptions (indeed, much weaker). We also note that the MR model is commonly illustrated with a non-genetic confounder affecting both traits. Our latent variable L is a genetic variable, and it is not analogous to the non-genetic confounder. Similar to MR, LCV is unaffected by non-genetic confounders (such a confounder may result in a phenotypic correlation that is unequal to the genetic correlation).
The GCP is defined as: which satisfies equation (1) . GCP is positive when trait 1 is partially genetically causal for trait 2. When GCP = 1, trait 1 is fully genetically causal for trait 2: q 1 = 1 and the causal effect size is q 2 = ρ g (Fig. 1b,e ). The LCV model is broadly related to dimension reduction techniques such as factor analysis 58 and independent components analysis 59 , although it differs in its modeling assumptions as well as its goal (causal inference); our inference strategy (mixed fourth moments) also differs.
Under the LCV model assumptions, we derive the estimation equation (2) In the second line, we used the independence assumption to discard crossterms of the form γ p π 3 and γ π 1 3 , and we used the symmetry assumption to discard terms of the form γ γ 1 2 3 . In the third and fourth lines, we used the independence assumption, which implies that γ π γ π γ 
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